Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POPBTOX: Botulinum toxin for prevention of shoulder deformity in infants with obstetric brachial plexus palsy
2024-520391-10-01Phase 3Authorised
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Jan 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of botulinum toxin type A in brachial plexus birth injury (BPBI) (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Planned start Jan 2025; status: authorised.
02
Drugs
botulinum toxin type A
03
Conditions
brachial plexus birth injury (BPBI)
Beyond the preview
Go deeper on 2024-520391-10-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-520391-10-01.